Market cap
$855 Mln
Revenue (TTM)
$375 Mln
P/E Ratio
12.3
P/B Ratio
1.4
Div. Yield
0 %
| InMode (INMD) | IceCure Medical (ICCM) | |
|---|---|---|
Market cap ($ Mln) |
855 | 8 |
Revenue ($ Mln) |
375 | 4 |
Net Profit ($ Mln) |
77.51 | -16.88 |
Net Margin (%) |
20.69 | -427.67 |
RoE (%) |
11.81 | -161.17 |
Price to Earnings |
12.27 | -- |
Price-To-Book |
1.36 | 0.65 |
Cashflow ($ Mln)
| InMode (INMD) | IceCure Medical (ICCM) | |
|---|---|---|
|
Cash From Operating Activities
|
85.26 | -14.57 |
|
Cash Flow from Investing Activities
|
186.03 | -0.04 |
|
Cash from Financing Activities
|
-126.06 | 15.83 |
|
Net Cash Inflow / Outflow
|
-- | -- |
Ratios
Profitability Ratios
| InMode (INMD) | IceCure Medical (ICCM) | |
|---|---|---|
|
ROCE (%)
|
13.33 | -181.10 |
|
ROE (%)
|
11.81 | -161.17 |
|
ROA (%)
|
9.85 | -64.21 |
|
EBIT Margin (%)
|
22.29 | -423.69 |
|
Net Margin (%)
|
20.69 | -427.67 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 |
Growth Ratios
| InMode (INMD) | IceCure Medical (ICCM) | |
|---|---|---|
|
Revenue Growth (%)
|
-6.71 | 41.62 |
|
EBIT Growth (%)
|
-37.62 | -5.44 |
|
Net Profit Growth (%)
|
-56.62 | -8.34 |
|
EPS Growth (%)
|
-50.09 | 19.81 |
|
Book Value Growth (%)
|
7.29 | 160.83 |
Valuation Ratios
| InMode (INMD) | IceCure Medical (ICCM) | |
|---|---|---|
|
Price / Earnings
|
10.03 | -0.10 |
|
Price / Book Value
|
1.36 | 0.65 |
|
Dividend Yield (%)
|
0.00 | 0.00 |
|
EV/EBITDA
|
3.71 | 0.05 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| InMode (INMD) | IceCure Medical (ICCM) | |
|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.01 |
|
Current Ratio
|
8.18 | 2.87 |
|
Quick Ratio
|
7.28 | 2.44 |
|
Interest Coverage
|
-- | -106.52 |
Operating Efficiency Ratios
| InMode (INMD) | IceCure Medical (ICCM) | |
|---|---|---|
|
Debtors to sales (%)
|
20.61 | 10.46 |
|
Asset Turnover
|
0.48 | 0.15 |
|
Receivable days
|
44.53 | 39.99 |
|
Inventory Days
|
341.98 | 391.29 |
|
Payable days
|
72.78 | 177.71 |
|
Cash Conversion Cycle
|
313.73 | 253.58 |